Is X-linked methyl-CpG binding protein 2 a new target for the treatment of Parkinson's disease

X-linked methyl-CpG binding protein 2 mutations can induce symptoms similar to those of Parkinson's disease and dopamine metabolism disorders, but the specific role of X-linked methyl-CpG binding protein 2 in the pathogenesis of Parkinson's disease remains unknown. In the present study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Teng, Zhang, Jie, Yuan, Xianhou, Yang, Jing, Ding, Wei, Huang, Xin, Wu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Research and Report Article: Neurodegenerative Disease and Neural Regeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145902/
https://www.ncbi.nlm.nih.gov/pubmed/25206503
http://dx.doi.org/10.3969/j.issn.1673-5374.2013.21.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145902/
https://www.ncbi.nlm.nih.gov/pubmed/25206503
http://dx.doi.org/10.3969/j.issn.1673-5374.2013.21.003

Ejemplares similares